Galapagos Past Earnings Performance

Past criteria checks 2/6

Galapagos's earnings have been declining at an average annual rate of -15.9%, while the Biotechs industry saw earnings growing at 15.7% annually. Revenues have been declining at an average rate of 11.7% per year. Galapagos's return on equity is 1.1%, and it has net margins of 12.6%.

Key information

-15.9%

Earnings growth rate

-16.7%

EPS growth rate

Biotechs Industry Growth14.8%
Revenue growth rate-11.7%
Return on equity1.1%
Net Margin12.6%
Next Earnings Update01 Aug 2024

Recent past performance updates

Recent updates

Galapagos NV (AMS:GLPG) Analysts Are More Bearish Than They Used To Be

Apr 19
Galapagos NV (AMS:GLPG) Analysts Are More Bearish Than They Used To Be

Galapagos NV's (AMS:GLPG) Shares Lagging The Industry But So Is The Business

Jan 03
Galapagos NV's (AMS:GLPG) Shares Lagging The Industry But So Is The Business

Lacklustre Performance Is Driving Galapagos NV's (AMS:GLPG) Low P/S

Jul 18
Lacklustre Performance Is Driving Galapagos NV's (AMS:GLPG) Low P/S

€41.78: That's What Analysts Think Galapagos NV (AMS:GLPG) Is Worth After Its Latest Results

May 06
€41.78: That's What Analysts Think Galapagos NV (AMS:GLPG) Is Worth After Its Latest Results

Here's Why We're Not Too Worried About Galapagos' (AMS:GLPG) Cash Burn Situation

Mar 29
Here's Why We're Not Too Worried About Galapagos' (AMS:GLPG) Cash Burn Situation

Revenue & Expenses Breakdown

How Galapagos makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTAM:GLPG Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24244311300
31 Dec 23240-41260
30 Sep 23544-1532720
30 Jun 23560-157280-11
31 Mar 23548-1812880
31 Dec 22241-711390
30 Sep 225776262223
30 Jun 22505-81230223
31 Mar 22507-1262190
31 Dec 21234-1211320
30 Sep 21474-2011950
30 Jun 21537-2192020
31 Mar 21488-2721960
31 Dec 20478-3111850
30 Sep 20455-3681680
30 Jun 20972751570
31 Mar 209481451200
31 Dec 19835149970
30 Sep 19865280740
30 Jun 19324-66520
31 Mar 19314-41440
31 Dec 18318-29400
30 Sep 18255-743496
30 Jun 18185-1263096
31 Mar 18161-1392896
31 Dec 17156-116270
30 Sep 17193-402668
30 Jun 17176-272668
31 Mar 1717742568
31 Dec 16152542468
30 Sep 1678-492349
30 Jun 1672-522249
31 Mar 1655-682149
31 Dec 1561-1182049
30 Sep 1575-721835
30 Jun 1582-571735
31 Mar 1588-441535
31 Dec 1490-371535
30 Sep 1486-32146
30 Jun 1492-251413
31 Mar 1494-211420
31 Dec 1397-171427
30 Sep 1355-10443
30 Jun 1377-2836

Quality Earnings: GLPG has a large one-off gain of €30.3M impacting its last 12 months of financial results to 31st March, 2024.

Growing Profit Margin: GLPG became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GLPG has become profitable over the past 5 years, growing earnings by -15.9% per year.

Accelerating Growth: GLPG has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: GLPG has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (3%).


Return on Equity

High ROE: GLPG's Return on Equity (1.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.